title: Genome scan on Swedish Alzheimer's disease families.
abstract: Alzheimer's disease (AD) is an age-related disease, which affects approximately 40% of the population at an age above 90 years. The heritability is estimated to be greater than 60% and there are rare autosomal dominant forms indicating a significant genetic influence on the disease process. Despite the successes in the early 1990s when four genes were identified, which directly cause the disease (APP, PSEN1 and PSEN2) or greatly increase the risk of disease development (APOE), it has proved exceedingly difficult to identify additional genes involved in the pathogenesis. However, several linkage and association studies have repeatedly supported the presence of susceptibility genes on chromosomes (chrms) 9, 10 and 12. The study populations have, however, mostly been of great genetic heterogeneity, and this may have contributed to the meagre successes in identifying the disease associated genetic variants. In this study, we have performed a genome wide linkage study on 71 AD families from the relatively genetically homogeneous Swedish population where it is also possible to study the genetic ancestry in public databases. We have performed nonparametric linkage analyses in the total family material as well as stratified the families with respect to the presence or absence of APOE varepsilon4. Our results suggest that the families included in this study are tightly linked to the APOE region, but do not show evidence of linkage to the previously reported linkages on chrms 9, 10 and 12. Instead, we observed the next highest LOD score on chromosome 5q35 in the total material. Further, the data suggest that the major fraction of families linked to this region is APOE varepsilon4 positive.
authors.affiliation: Department Neurotec, Karolinska Institutet Sumitomo Pharmaceuticals Alzheimer Center, Karolinska Institutet, Novum, Huddinge, Sweden.
authors.forename: A
authors.initials: A
authors.lastname: Sillén
authors.forename: C
authors.initials: C
authors.lastname: Forsell
authors.forename: L
authors.initials: L
authors.lastname: Lilius
authors.forename: K
authors.initials: K
authors.lastname: Axelman
authors.forename: B F
authors.initials: BF
authors.lastname: Björk
authors.forename: P
authors.initials: P
authors.lastname: Onkamo
authors.forename: J
authors.initials: J
authors.lastname: Kere
authors.forename: B
authors.initials: B
authors.lastname: Winblad
authors.forename: C
authors.initials: C
authors.lastname: Graff
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000235:genetics*; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics*; D016022:Case-Control Studies; D002874:Chromosome Mapping; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D015894:Genome, Human; D006801:Humans; D008126:Lod Score; D008297:Male; D018895:Microsatellite Repeats; D008875:Middle Aged; D010375:Pedigree; D018709:Statistics, Nonparametric; D013548:Sweden
chemical_list: D053327:Apolipoprotein E4; D001057:Apolipoproteins E